Wakamoto Pharmaceutical Co (TSE:4512) Change In Payables And Accrued Expense : 円0 Mil (TTM As of Sep. 2024)

View and export this data going back to 1949. Start your Free Trial

What is Wakamoto Pharmaceutical Co Change In Payables And Accrued Expense?

Wakamoto Pharmaceutical Co's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was 円0 Mil. It means Wakamoto Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Mar. 2024 to Sep. 2024 .

Wakamoto Pharmaceutical Co's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was 円0 Mil. It means Wakamoto Pharmaceutical Co's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

Wakamoto Pharmaceutical Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Wakamoto Pharmaceutical Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wakamoto Pharmaceutical Co Change In Payables And Accrued Expense Chart

Wakamoto Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Wakamoto Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Wakamoto Pharmaceutical Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Wakamoto Pharmaceutical Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Wakamoto Pharmaceutical Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Wakamoto Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wakamoto Pharmaceutical Co Ltd (TSE:4512) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-2-2, Nihonbashi Honcho, Chuo-ku, Tokyo, JPN, 103-8330

Website

http://www.wakamoto-pharm.co.jp

Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.

Wakamoto Pharmaceutical Co Headlines

No Headlines